| A pharmacological exploration of targeted drug therapy in non-small cell lung cancer AP Jayan, KR Anandu, K Madhu, VN Saiprabha Medical Oncology 39 (10), 147, 2022 | 7 | 2022 |
| Pyrimidine derivatives as EGFR tyrosine kinase inhibitors in non‐small‐cell lung cancer: A comprehensive review A Kizhakkedath Ratheesh, A Pottankottu Jayan, AT Presanna, SV Nirmala Chemical Biology & Drug Design 100 (4), 599-621, 2022 | 6 | 2022 |
| Unraveling the prevalence of various signalling pathways in non-small-cell lung cancer: A review AS Nair, AP Jayan, KR Anandu, VN Saiprabha, LK Pappachen Molecular and Cellular Biochemistry 478 (12), 2875-2890, 2023 | 3 | 2023 |
| Signaling mechanisms involved in the regulation of remyelination in multiple sclerosis: A mini review M Devanand, S VN, K Madhu Journal of Molecular Medicine 101 (6), 637-644, 2023 | 2 | 2023 |
| Multifaceted roles of mitochondrial dysfunction in diseases: from powerhouses to saboteurs SS Prabhu, AS Nair, SV Nirmala Archives of Pharmacal Research 46 (9), 723-743, 2023 | 1 | 2023 |
| Design of chalcones of 7-azaindole as raf-B inhibitors D Giles, VN Saiprabha, G Yeshna Journal of Advanced Chemical Sciences, 606-608, 2019 | 1 | 2019 |
| Discovery Of Novel Sulphamidopyrimidine Derivatives As Novel Brd4 And Cox2 Inhibitors In Cancer And Inflammation–Synthesis, Structure–Activity Relationship And In-Vitro Efficacy S VN, S Janadri Proceedings of International Conference on Drug Discovery (ICDD), 2020 | | 2020 |
| Design, Synthesis and Structural Activity Relationship Studies of Novel Pyrimidine Derivatives as Potent Anti-Inflammatory and Anticancer Agents SP VN PQDT-Global, 2019 | | 2019 |
| Journal of Advanced Chemical Sciences D Giles, VN Saiprabha, G Yeshna | | |
